Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josep M Gatell

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Plos One|February 2, 2011
A new multidisciplinary home care telemedicine system to monitor stable chronic human immunodeficiency virus-infected patients: a randomized studyAgathe León, César Cáceres, Emma Fernández, et al.
AIDS (London, England)|October 6, 2018
Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infectionLorna Leal, Alberto C Guardo, Sara Morón-López, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|July 28, 2016
Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adultsAntonio Rivero, José Antonio Pérez-Molina, Antonio Javier Blasco, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|May 24, 2017
Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adultsAntonio Rivero, José Antonio Pérez-Molina, Antonio Javier Blasco, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|June 10, 2018
Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adultsJosé Antonio Pérez-Molina, Esteban Martínez, Antonio Javier Blasco, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 14, 2009
Safety of Switching Nevirapine Twice Daily to Nevirapine Once Daily in Virologically Suppressed PatientsDaniel Podzamczer, Montserrat Olmo, Jose Sanz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 30, 2016
Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus CoinfectionDavid Nicolás, Anna Esteve, Anna Cuadros, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Plos One|February 2, 2011
A new multidisciplinary home care telemedicine system to monitor stable chronic human immunodeficiency virus-infected patients: a randomized studyAgathe León, César Cáceres, Emma Fernández, et al.
AIDS (London, England)|October 6, 2018
Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infectionLorna Leal, Alberto C Guardo, Sara Morón-López, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|July 28, 2016
Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adultsAntonio Rivero, José Antonio Pérez-Molina, Antonio Javier Blasco, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|May 24, 2017
Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adultsAntonio Rivero, José Antonio Pérez-Molina, Antonio Javier Blasco, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|June 10, 2018
Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adultsJosé Antonio Pérez-Molina, Esteban Martínez, Antonio Javier Blasco, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 14, 2009
Safety of Switching Nevirapine Twice Daily to Nevirapine Once Daily in Virologically Suppressed PatientsDaniel Podzamczer, Montserrat Olmo, Jose Sanz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 30, 2016
Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus CoinfectionDavid Nicolás, Anna Esteve, Anna Cuadros, et al.
Pageof 7